Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study

2006197 citationsJournal Article

Authors

I. Tomida

Augusto Azuara‐Blanco · Centre of Experimental Medicine of the Slovak Academy of Sciences

Heather House

Maggie Flint · GW Pharmaceuticals (United Kingdom)

Roger G. Pertwee · University of Aberdeen

Philip Robson

Abstract

A single 5 mg sublingual dose of Delta-9-THC reduced the IOP temporarily and was well tolerated by most patients. Sublingual administration of 20 mg CBD did not reduce IOP, whereas 40 mg CBD produced a transient increase IOP rise.

Topics & Keywords

Cannabis and Cannabinoid Research Alcohol Consumption and Health Effects Sleep and Wakefulness Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Glaucoma

Volume 15, Issue 5, pp. 349-353

DOI: 10.1097/01.ijg.0000212260.04488.60

Field-Weighted Citation Impact: 2.60